Exor Blinks: A €500M Buyback, a 56% Discount, and €4B It Won't Spend
After 18 months of 'patient' sitting, Exor swaps cash-hoarding for NAV-per-share arithmetic — as Stellantis drags the portfolio and Ferrari eats 39% of GAV.
EXO.AS · Earnings Call · 2026-09-23
A portfolio manager that finally acted on its own discount
For a year and a half, Exor's message was one verb — wait. On the prior calls, John Elkann leaned on the same refrain: cash is king, be patient, and buybacks are merely one tool in the box. The H1 2026 call broke that spell. CFO Guido De Boer announced a €500 million on-market buyback to run over six months, and — critically — framed it not as a routine return of capital but as a verdict on the share price itself. The company described the setup as a "triple whammy":
The discount is at a very high level, 56% is a long time that we reached that. Our companies are at depressed levels, and we have a cash position that is well utilized... it's not an opportunistic transaction.
The vocabulary in Exor's own keyword set shifted with it. The fresh top themes for the quarter include substantial discount, capital allocation decision, Board yesterday, and — notably new — concentration risk. This is a company whose equity story for years was the discount; now it's the discount plus a live decision to do something about it. Contrast that with the prior-year call, when Elkann was still defending a fortress-balance-sheet stance: “we have been aggressively buying back shares, EUR 2.5 billion in the last years, which is approximately close to 15% of our capital.” — John Elkann, Chairman and CEO · 2026-03-24 So the buyback is not new in kind — but the *timing and framing* are: after spending 2025 and early 2026 telling analysts they were patient, Exor pulled the trigger.
The plumbing: Stellantis down, Ferrari heavy, Philips wider
The reason the discount got so wide sits under the hood. Exor's NAV fell €1.2 billion in the period, and De Boer was explicit that the culprit was share price weakness at Stellantis, which he said drove "60% the majority of change" in portfolio performance. CNH was a bright spot (8% to 10% of GAV), Ferrari crept from 32% to 34%, and cash rose to 6%. But the constellation of listed holdings is now the whole story: listed company movements, not unlisted marks, drove the drawdown.
The sharpest exchange was on Ferrari concentration. Analyst Filippe Goossens pressed on the ~38-39% weight, and De Boer answered by referencing the block trade of 18 months ago: “At that time, the concentration of Ferrari was reaching 50%... the multiple at which Ferrari trades is significantly below the multiple it was trading at when we did the transaction.” — Guido de Boer, Chief Financial Officer · 2026-09-23 The implication: they trimmed when it was expensive, and at ~39% with a lower multiple they're comfortable — but won't say Ferrari is off the table as a funding source. That is a soft concession new to this call.
Philips moved too. The stake cap was raised from 20% to 22%, which De Boer called a Philips vote of trust: “Previously, we had a limit of 20% but now increased to 22%. It doesn't mean that there is any action now taken to increase that or it's imminent.” — Guido de Boer, Chief Financial Officer · 2026-09-23 Stellantis got the opposite treatment — a no-comment on a rumored capital raise: “we fully endorse the plan that has been announced by the management... I am not aware of any of those plans.” — Guido de Boer, Chief Financial Officer · 2026-09-23 Recall that a year ago Elkann was cheerleading Stellantis' hybrid issuance; now the topic has migrated to whether it needs more cash at all.
Four billion and nowhere to put it
The most quotable number on the call is the firepower — and the most interesting thing about it is that it is unspent. De Boer's bridge: ~€1.4bn starting cash, €2.7bn of disposal proceeds, dividends and capital calls net out to roughly €4 billion, minus the buyback leaves €3.5bn. He spelled it out plainly: “The firepower is EUR 4 billion. From that, you would deduct EUR 500 million for buyback. So after buyback, just EUR 3.5 billion.” — Guido de Boer, Chief Financial Officer · 2026-09-23
And what gets bought with it? Still nothing. The search remains for large Portfolio construction pieces — De Boer quantified the target: stakes of 15-20% in large caps for at least €2bn each, inside sectors with structural tailwinds. Healthcare, luxury and tech remain the waterholes — the luxury brand theme is a recurring one across quarters — but he stressed they're "not bound" to them. On why nothing has closed in 18 months, he reached for the sharpest comparison available: “We did not miss any transactions. Look at Berkshire Hathaway and their cash position.” — Guido de Boer, Chief Financial Officer · 2026-09-23
Meanwhile the divestment machine kept running: Iveco's defense unit already sold to Leonardo, Tata's tender live, GEDI/Lifenet/NUO gone, and the just-signed Welltec sale returning a MOIC of 2.4x. That is the quiet counter-narrative — a company buying back its own discount while simultaneously proving it can sell assets at gains. Whether that combination is value-accretive or simply a stalled acquirer redeploying into itself is the question the next two quarters will answer.
One final contrast worth flagging: the broad-market keyword set this quarter is dominated by net tariff refunds, AI infrastructure and AI data center capex — a market trading on cyclical, flow-driven narratives. Exor's own keyword board reads like a different universe: discount, divestment, buyback, and turbulent times. That divergence is the insight. Exor is not riding a market wave; it is explicitly positioning as the patient, contrarian holder while everyone else pays up.